| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 426.417.828 $ | 82,18 | 21.178.132 | |||||||
| Apellis Pharmaceuticals Inc | Apellis Pharmaceuticals Inc COM USD0.0001 | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 7.954.538 $ | 1,53 | 194.250 | |
| Revolution Medicines Inc | Revolution Medicines Inc COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 7.025.562 $ | 1,35 | 48.748 | |
| Travere Therapeutics Inc | Travere Therapeutics Inc COM | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 6.910.502 $ | 1,33 | 164.067 | |
| ARROWHEAD PHARMACEUTICALS INC | Arrowhead Pharmaceuticals Inc COM USD0.001 | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 6.139.842 $ | 1,18 | 83.558 | |
| Twist Bioscience Corporation | Twist Bioscience Corporation COM USD0.00001 | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 6.055.595 $ | 1,17 | 103.603 | |
| Summit Therapeutics Inc. | SUMMIT THERAPEUTICS INC | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 5.984.057 $ | 1,15 | 278.847 | |
| Alkermes PLC | Alkermes PLC COM USD0.01 | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 5.893.283 $ | 1,14 | 174.823 | |
| TG Therapeutics Inc | TG Therapeutics Inc COM USD0.001 | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 5.846.642 $ | 1,13 | 173.080 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc USD0.0001 | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 5.820.120 $ | 1,12 | 11.249 | |
| Beam Therapeutics Inc. | Beam Therapeutics Incorporation COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 5.646.051 $ | 1,09 | 186.154 | |
| Apogee Therapeutics Inc. | APOGEE THERAPEUTICS INC | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 5.388.347 $ | 1,04 | 65.006 | |
| Scholar Rock Holding Corp. | SCHOLAR ROCK HOLDING CORP | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 5.240.129 $ | 1,01 | 112.425 | |
| PRAXIS PRECISION MEDICINES INC | PRAXIS PRECISION MEDICINES I | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 5.211.276 $ | 1,00 | 16.345 | |
| EXELIXIS INC | Exelixis, Inc. COM USD0.001 | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 5.169.853 $ | 1,00 | 116.281 | |
| Mirum Pharmaceuticals Inc. | Mirum Pharmaceuticals Inc. COM USD0.0001 | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 5.149.353 $ | 0,99 | 52.917 | |
| United Therapeutics Corporation | United Therapeutics Corporation COM USD0.01 | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 5.093.014 $ | 0,98 | 8.914 | |
| Natera Inc. | Natera Incorporation COM USD0.0001 | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 5.091.327 $ | 0,98 | 24.696 | |
| Celcuity Inc. | CELCUITY INC | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 5.089.540 $ | 0,98 | 41.941 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG COM CHF0.03 | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 5.089.280 $ | 0,98 | 97.235 | |
| Krystal Biotech Inc | Krystal Biotech Inc COM USD0.00001 | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 4.992.644 $ | 0,96 | 19.037 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc COM USD0.00001 | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 4.980.269 $ | 0,96 | 50.321 | |
| NEUROCRINE BIOSCIENCES INC | Neurocrine Biosciences Inc COM USD0.001 | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 4.934.465 $ | 0,95 | 37.476 | |
| Incyte Corporation. | Incyte Corporation. COM USD0.001 | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 4.886.112 $ | 0,94 | 51.287 | |
| CG Oncology Inc. | CG ONCOLOGY INC | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 4.883.366 $ | 0,94 | 73.170 | |
| Cytokinetics Inc | Cytokinetics Inc COM USD0.001 | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 4.880.719 $ | 0,94 | 76.297 | |
| NUVALENT INC | NUVALENT INC | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 4.865.686 $ | 0,94 | 48.521 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. COM USD0.001 | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 4.852.746 $ | 0,94 | 64.911 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc COM USD0.001 | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 4.835.693 $ | 0,93 | 68.003 | |
| Vaxcyte Inc | Vaxcyte Inc COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 4.830.369 $ | 0,93 | 84.388 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 4.827.962 $ | 0,93 | 59.553 | |
| Biogen Inc | Biogen Inc COM USD0.0005 | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 4.823.612 $ | 0,93 | 25.484 | |
| Cogent Biosciences Inc. | Cogent Biosciences Inc. COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 4.815.688 $ | 0,93 | 134.554 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. COM USD0.001 | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 4.809.756 $ | 0,93 | 73.928 | |
| Insmed Inc | Insmed Inc COM USD0.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 4.748.374 $ | 0,92 | 34.830 | |
| ALNYLAM PHARMACEUTICALS INC | Alnylam Pharmaceuticals Inc. COM USD0.01 | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 4.689.083 $ | 0,90 | 15.151 | |
| Roivant Sciences Ltd | ROIVANT SCIENCES LTD | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 4.682.372 $ | 0,90 | 164.121 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc COM USD0.001 | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 4.648.644 $ | 0,90 | 73.023 | |
| Arcutis Biotherapeutics Inc. | ARCUTIS BIOTHERAPEUTICS INC | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 4.574.131 $ | 0,88 | 196.991 | |
| Spyre Therapeutics Inc | SPYRE THERAPEUTICS INC | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 4.561.552 $ | 0,88 | 61.270 | |
| Soleno Therapeutics Inc | SOLENO THERAPEUTICS INC | EC | 834203309 | Long | Börsenkurs (Stufe 1) | 4.526.621 $ | 0,87 | 85.699 | |
| AbbVie Inc. | AbbVie Inc. COM USD0.01 | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 4.505.765 $ | 0,87 | 21.322 | |
| Amgen Inc. | Amgen Inc. COM USD0.0001 | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 4.450.351 $ | 0,86 | 12.853 | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals, Inc. COM USD0.001 | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 4.431.145 $ | 0,85 | 6.267 | |
| ULTRAGENYX PHARMACEUTICAL INC | Ultragenyx Pharmaceuticals Inc COM USD0.001 | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 4.396.227 $ | 0,85 | 178.057 | |
| ACADIA PHARMACEUTICALS INC | Acadia Pharmaceuticals Inc COM USD0.0001 | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 4.389.918 $ | 0,85 | 195.542 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc COM USD0.001 | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 4.387.745 $ | 0,85 | 53.930 | |
| Gilead Sciences Inc. | Gilead Sciences, Inc. COM USD0.001 | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 4.351.084 $ | 0,84 | 33.255 | |
| Biomarin Pharmaceutical Inc. | Biomarin Pharmaceutical Inc. COM USD0.001 | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 4.338.946 $ | 0,84 | 80.485 | |
| Viking Therapeutics Inc. | VIKING THERAPEUTICS INC | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 4.232.903 $ | 0,82 | 135.757 | |
| VERTEX PHARMACEUTICALS INC | Vertex Pharmaceuticals Incorporated COM USD0.01 | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 4.213.967 $ | 0,81 | 9.860 | |
| ImmunityBio Inc | IMMUNITYBIO INC | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 4.167.991 $ | 0,80 | 587.041 | |
| Immunovant Inc | Immunovant Inc COM | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 3.991.591 $ | 0,77 | 147.047 | |
| Moderna Inc | Moderna Inc COM USD0.0001 | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 3.984.882 $ | 0,77 | 86.741 | |
| Vera Therapeutics Inc. | VERA THERAPEUTICS INC | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 3.901.325 $ | 0,75 | 109.557 | |
| Immunome Inc | IMMUNOME INC | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 3.857.246 $ | 0,74 | 168.145 | |
| Disc Medicine Inc | DISC MEDICINE INC | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 3.823.649 $ | 0,74 | 57.978 | |
| Veracyte Inc | Veracyte Inc COM USD0.001 | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 3.692.669 $ | 0,71 | 112.171 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc COM USD0.0001 | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 3.656.526 $ | 0,70 | 175.121 | |
| Catalyst Pharmaceuticals Inc. | Catalyst Pharmaceuticals Inc. COM STK USD0.001 | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 3.655.465 $ | 0,70 | 129.949 | |
| BIOCRYST PHARMACEUTICALS INC | BioCryst Pharmaceuticals Inc. COM USD0.01 | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 3.492.754 $ | 0,67 | 381.305 | |
| Dyne Therapeutics Inc. | DYNE THERAPEUTICS INC | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 3.456.315 $ | 0,67 | 196.941 | |
| Kodiak Sciences Inc | KODIAK SCIENCES INC | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 3.346.308 $ | 0,64 | 76.962 | |
| RECURSION PHARMACEUTICALS INC | Recursion Pharmaceuticals Inc CL A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 3.316.666 $ | 0,64 | 958.574 | |
| GRAIL Inc | GRAIL INC | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 3.249.786 $ | 0,63 | 59.651 | |
| Arcus Biosciences Inc. | Arcus Biosciences Inc. COM USD0.0001 | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 3.160.113 $ | 0,61 | 123.926 | |
| Agios Pharmaceuticals Inc | Agios Pharmaceuticals Inc COM USD0.001 | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 3.096.380 $ | 0,60 | 110.585 | |
| Denali Therapeutics Inc | Denali Therapeutics Inc COM USD0.01 | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 3.036.216 $ | 0,59 | 162.191 | |
| Oruka Therapeutics Inc | ORUKA THERAPEUTICS INC | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 2.981.034 $ | 0,57 | 43.576 | |
| Dianthus Therapeutics Inc | DIANTHUS THERAPEUTICS INC | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 2.950.519 $ | 0,57 | 33.605 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc COM USD0.0001 | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 2.898.294 $ | 0,56 | 215.007 | |
| Erasca Inc | ERASCA INC | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 2.888.216 $ | 0,56 | 271.194 | |
| ADMA BIOLOGICS INC | Adma Biologics Inc COM USD0.0001 | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 2.887.159 $ | 0,56 | 281.674 | |
| Syndax Pharmaceuticals Inc. | Syndax Pharmaceuticals Inc. COM USD0.0001 | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 2.876.806 $ | 0,55 | 134.242 | |
| Ardelyx Inc | ARDELYX INC | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 2.778.813 $ | 0,54 | 438.991 | |
| IDEAYA Biosciences Inc. | IDEAYA Biosciences Inc. COM USD0.0001 | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 2.715.030 $ | 0,52 | 93.300 | |
| Mineralys Therapeutics Inc. | MINERALYS THERAPEUTICS INC | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 2.706.467 $ | 0,52 | 101.556 | |
| Nurix Therapeutics Inc. | NURIX THERAPEUTICS INC | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 2.687.648 $ | 0,52 | 160.937 | |
| Tango Therapeutics Inc. | TANGO THERAPEUTICS INC | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 2.442.520 $ | 0,47 | 112.975 | |
| Celldex Therapeutics Inc. | Celldex Therapeutics Inc. COM USD0.001(POST REV SPLT | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 2.302.159 $ | 0,44 | 70.017 | |
| CAPRICOR THERAPEUTICS INC | CAPRICOR THERAPEUTICS INC | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 2.253.487 $ | 0,43 | 67.108 | |
| Vericel Corporation | Vericel Corporation COM NPV | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 2.220.324 $ | 0,43 | 63.931 | |
| Inhibrx Biosciences Inc. | INHIBRX BIOSCIENCES INC | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 2.191.531 $ | 0,42 | 16.961 | |
| Monte Rosa Therapeutics Inc | MONTE ROSA THERAPEUTICS INC | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 2.156.462 $ | 0,42 | 112.609 | |
| Novavax Inc | NOVAVAX INC | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 2.118.979 $ | 0,41 | 267.379 | |
| Biohaven Ltd | Biohaven Ltd COM NPV | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 2.111.334 $ | 0,41 | 220.160 | |
| Stoke Therapeutics Inc | STOKE THERAPEUTICS INC | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 2.109.491 $ | 0,41 | 64.471 | |
| Relay Therapeutics Inc | Relay Therapeutics Inc COM | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 2.101.023 $ | 0,40 | 162.116 | |
| Taysha Gene Therapies Inc. | TAYSHA GENE THERAPIES INC | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 2.062.634 $ | 0,40 | 322.791 | |
| Viridian Therapeutics Inc | Viridian Therapeutics Inc COM | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 2.059.946 $ | 0,40 | 152.815 | |
| Olema Pharmaceuticals Inc. | OLEMA PHARMACEUTICALS INC | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 2.039.851 $ | 0,39 | 141.558 | |
| Palvella Therapeutics Inc. | PALVELLA THERAPEUTICS INC | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 2.015.266 $ | 0,39 | 15.705 | |
| Uniqure N.V. | UNIQURE NV | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 1.938.402 $ | 0,37 | 97.163 | |
| AnaptysBio Inc. | ANAPTYSBIO INC | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 1.927.729 $ | 0,37 | 29.328 | |
| Corvus Pharmaceuticals Inc | CORVUS PHARMACEUTICALS INC | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.841.043 $ | 0,35 | 121.201 | |
| MANNKIND CORP | Mannkind Corporation COM USD0.01 | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 1.771.356 $ | 0,34 | 625.921 | |
| Caredx Inc | Caredx Inc COM USD0.001 | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 1.763.481 $ | 0,34 | 84.742 | |
| KALVISTA PHARMACEUTICALS INC | KALVISTA PHARMACEUTICALS INC | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 1.644.149 $ | 0,32 | 61.671 | |
| Iovance Biotherapeutics Inc | Iovance Biotherapeutics Inc COM USD0.000041666 | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 1.565.931 $ | 0,30 | 466.051 | |
| VIR Biotechnology Inc | VIR Biotechnology Inc COM | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 1.477.855 $ | 0,28 | 144.675 | |
| GERON CORP | Geron Corp. COM USD0.001 | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 1.464.602 $ | 0,28 | 951.040 | |
| Precigen Inc | PRECIGEN INC | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 1.429.272 $ | 0,28 | 343.575 | |
| SELLAS LIFE SCIENCES GROUP INC | SELLAS LIFE SCIENCES GROUP I | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 1.328.902 $ | 0,26 | 268.465 | |
| Tyra Biosciences Inc | TYRA BIOSCIENCES INC | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 1.303.612 $ | 0,25 | 37.514 | |
| Absci Corp. | ABSCI CORP | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 1.290.291 $ | 0,25 | 259.355 | |
| Annexon Inc | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 1.284.262 $ | 0,25 | 218.784 | |
| Kura Oncology Inc. | Kura Oncology Incorporation COM USD0.0001 | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 1.275.008 $ | 0,25 | 144.395 | |
| Sana Biotechnology Inc | SANA BIOTECHNOLOGY INC | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 1.252.072 $ | 0,24 | 380.569 | |
| ArriVent BioPharma Inc. | ARRIVENT BIOPHARMA INC | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 1.246.616 $ | 0,24 | 40.097 | |
| ORIC Pharmaceuticals Inc. | ORIC PHARMACEUTICALS INC | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 1.228.005 $ | 0,24 | 124.292 | |
| Rigel Pharmaceuticals Inc. | RIGEL PHARMACEUTICALS INC | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 1.171.924 $ | 0,23 | 40.551 | |
| Janux Therapeutics Inc | JANUX THERAPEUTICS INC | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 1.171.327 $ | 0,23 | 81.512 | |
| Cytomx Therapeutics Inc | CYTOMX THERAPEUTICS INC | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 1.089.309 $ | 0,21 | 258.130 | |
| Savara Inc | SAVARA INC | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 1.065.695 $ | 0,21 | 203.377 | |
| ARS Pharmaceuticals Inc | ARS PHARMACEUTICALS INC | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 1.045.848 $ | 0,20 | 126.616 | |
| ZENAS BIOPHARMA INC | ZENAS BIOPHARMA INC | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 1.001.684 $ | 0,19 | 51.847 | |
| Cullinan Therapeutics Inc | CULLINAN ONCOLOGY INC | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 975.996 $ | 0,19 | 74.789 | |
| Xencor Inc | Xencor Inc COM USD0.01 | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 970.506 $ | 0,19 | 81.350 | |
| Ironwood Pharmaceuticals, Inc. | IRONWOOD PHARMACEUTICALS INC | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 961.769 $ | 0,19 | 233.156 | |
| Sionna Therapeutics Inc. | SIONNA THERAPEUTICS INC | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 922.105 $ | 0,18 | 23.827 | |
| Bicara Therapeutics Inc. | BICARA THERAPEUTICS INC | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 882.687 $ | 0,17 | 40.903 | |
| HYPERLIQUID STRATEGIES INC | HYPERLIQUID STRATEGIES | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 860.378 $ | 0,17 | 142.920 | |
| Prime Medicine Inc | PRIME MEDICINE INC | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 822.561 $ | 0,16 | 232.034 | |
| VOR BIOPHARMA INC | VOR BIOPHARMA INC | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 778.950 $ | 0,15 | 54.358 | |
| Emergent Biosolutions Inc | EMERGENT BIOSOLUTIONS INC | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 754.732 $ | 0,15 | 91.705 | |
| Regenxbio Inc. | REGENXBIO INC | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 713.285 $ | 0,14 | 79.519 | |
| VANDA PHARMACEUTICALS INC | VANDA PHARMACEUTICALS INC | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 705.392 $ | 0,14 | 99.351 | |
| FIRST TRACKS BIOTHERAPEUTICS INC | FIRST TRACKS BIOTHERAPEUTICS | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 682.463 $ | 0,13 | 29.328 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D MOLECULAR THERAPEUTICS IN | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 681.633 $ | 0,13 | 76.847 | |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 647.305 $ | 0,12 | 303.899 | |
| Altimmune Inc. | ALTIMMUNE INC | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 647.200 $ | 0,12 | 248.923 | |
| Verastem Inc | VERASTEM INC | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 641.310 $ | 0,12 | 117.456 | |
| Prothena Corporation PLC | PROTHENA CORP PLC | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 634.048 $ | 0,12 | 57.328 | |
| Lexeo Therapeutics Inc | LEXEO THERAPEUTICS INC | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 618.449 $ | 0,12 | 108.595 | |
| Myriad Genetics Inc. | Myriad Genetics Inc. COM USD0.01 | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 598.234 $ | 0,12 | 125.944 | |
| Arbutus Biopharma Corp. | ARBUTUS BIOPHARMA CORP | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 555.387 $ | 0,11 | 132.235 | |
| ROCKET PHARMACEUTICALS INC | ROCKET PHARMACEUTICALS INC | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 528.929 $ | 0,10 | 151.991 | |
| OCUGEN INC | OCUGEN INC | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 526.778 $ | 0,10 | 304.496 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corp. USD0.001 | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 516.788 $ | 0,10 | 154.727 | |
| Akebia Therapeutics Inc. | AKEBIA THERAPEUTICS INC | EC | 00972D105 | Long | Börsenkurs (Stufe 1) | 485.869 $ | 0,09 | 352.079 | |
| Invivyd Inc | INVIVYD INC | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 461.535 $ | 0,09 | 329.668 | |
| MiMedx Group Inc. | MiMedx Group Inc. COM USD0.001 | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 447.169 $ | 0,09 | 133.086 | |
| PERSPECTIVE THERAPEUTICS INC | PERSPECTIVE THERAPEUTICS INC | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 389.598 $ | 0,08 | 99.897 | |
| Compass Therapeutics Inc | COMPASS THERAPEUTICS INC | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 373.155 $ | 0,07 | 210.822 | |
| Replimune Group Inc | REPLIMUNE GROUP INC | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 327.729 $ | 0,06 | 127.521 | |
| DAMORA THERAPEUTICS INC | DAMORA THERAPEUTICS INC | EC | 36322Q206 | Long | Börsenkurs (Stufe 1) | 140.412 $ | 0,03 | 5.472 | |
| VERVE THERAPEUTICS INC (CVR) | VERVE THERAPEUTICS INC (CVR) | EC | 925CVR011 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 82.531 | |
| NOVOB DC CVR | NOVOB DC CVR | EC | 009CVR044 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 128.720 | |
| INHIBRX INC CVR | INHIBRX INC CVR | EC | 457CVR017 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 164.173 | |
| OMNIAB INC | OmniAb Inc. USD0.0001 A (USD12.5 VESTING) | EC | 68218J202 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 29.566 | |
| 426.417.828 $ | 82,18 | 21.178.132 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
SEC-Meldungen und stellen keine Bewertung oder Empfehlung zu einzelnen Wertpapieren,
Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher SEC-Meldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.